Log In
Print
BCIQ
Print
Print this Print this
 

IN-105

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionOral conjugated insulin molecule
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today